Page last updated: 2024-09-03

sq 28603 and Cardiomyopathies, Primary

sq 28603 has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asaad, MM; Dorso, CR; Fox, M; Natarajan, V; Panchal, BC; Trippodo, NC	1

Other Studies

1 other study(ies) available for sq 28603 and Cardiomyopathies, Primary

Article	Year
Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathies; Cricetinae; Drug Synergism; Enalaprilat; Hemodynamics; Kidney; Male; Neprilysin	1993

Article

Year

Combined inhibition of neutral endopeptidase and angiotensin converting enzyme in cardiomyopathic hamsters with compensated heart failure.

The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1

Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathies; Cricetinae; Drug Synergism; Enalaprilat; Hemodynamics; Kidney; Male; Neprilysin

1993